These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6176978)

  • 1. Chemotherapy of advanced prostatic cancer with peplomycin.
    Koiso K; Niijima T
    Prostate Suppl; 1981; 1():103-10. PubMed ID: 6176978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pepleomycin in prostatic cancer. A preliminary report.
    Niijima T; Koiso K
    Scand J Urol Nephrol Suppl; 1980; 55():177-9. PubMed ID: 6163206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of prostatic cancer by intramuscular administration and intratumor injection of peplomycin].
    Fujimoto Y; Okano M; Takeuchi T; Saito A; Fujihiro S; Kuriyama M; Sakai S; Nishiura T
    Hinyokika Kiyo; 1983 Nov; 29(11):1433-41. PubMed ID: 6203378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peplomycin and liblomycin, a new analogues of bleomycin.
    Takita T; Ogino T
    Biomed Pharmacother; 1987; 41(5):219-26. PubMed ID: 2444281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of clinical studies of pepleomycin.
    Oka S
    Recent Results Cancer Res; 1980; 74():163-71. PubMed ID: 6160600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Continuous subcutaneous infusion of peplomycin for advanced prostatic cancer patients].
    Satake I; Tari K
    Hinyokika Kiyo; 1985 May; 31(5):875-83. PubMed ID: 2413747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experiences with pepleomycin].
    Furue H; Komita T; Mugitani H; Fuse K; Hakozaki M; Kobayashi H; Takahashi T; Hirota F; Yoshihira T
    Gan To Kagaku Ryoho; 1982 May; 9(5):930-5. PubMed ID: 6191706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study on peplomycin for esophageal cancer].
    Katayama K; Wada T; Kasai Y; Sano F; Abo S; Miura H; Kasai M; Nishihira T; Iwatsuka M; Obitsu R; Nabeya K; Ri S; Menjo M; Hatano R; Akiyama H; Tsurumaru M; Abe O; Ando N; Sato H; Isono K; Goto H; Amano T; Takagi I; Fujita H; Fujimaki M; Saito J; Okagawa K; Mizunoya S; Sakai K; Hamanaka Y; Taniguchi K; Kabuto T; Saito Y; Sato M; Hattori T; Takiyama W; Koga S; Maeda M; Inokuchi K; Sugimachi K; Sannohe Y; Doki K; Kakegawa T; Takeoka A; Tomita M; Nakamura Y; Nishi M; Suenaga T
    Jpn J Antibiot; 1982 Sep; 35(9):2293-313. PubMed ID: 6183468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical use of peplomycin in esophageal cancer].
    Hirai T; Takiyama W; Miyoshi Y; Hattori T; Yamagata S; Ohya M
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1249-55. PubMed ID: 6191710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial of peplomycin in squamous cell carcinoma of the lung.
    Sørensen PG; Rørth M; Hansen HH; Dombernowsky P; Høst H
    Eur J Cancer Clin Oncol; 1983 Jan; 19(1):25-7. PubMed ID: 6189718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of non-Hodgkin's lymphoma with NK-631 (peplomycin)--with special reference to the effect on T and non-T cell lymphomas].
    Kamihira S; Jinnai I; Kinoshita K; Ichimaru M
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):289-92. PubMed ID: 6191697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundamental studies on a new antitumor antibiotic peplomycin.
    Matsuda A
    Prostate Suppl; 1981; 1():119-23. PubMed ID: 6176979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I evaluation of peplomycin with special reference to pulmonary toxicity.
    Sørensen PG; Rørth M; Hansen HH
    Eur J Cancer Clin Oncol; 1983 Mar; 19(3):319-25. PubMed ID: 6190655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of peplomycin sulfate to the recurrent and metastatic breast cancer].
    Numata M; Hosoe S; Ito N; Yokozawa S; Hayashi S; Maeda T
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1521-5. PubMed ID: 6084038
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic effect of peplomycin in cervical cancer, with special reference to pathohistological studies].
    Noda K; Sugawa T; Kurihara S; Suzuki M; Akiya K; Ueda K; Takamizawa H; Fukuda T; Chihara T; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1983 Oct; 18(7):1921-31. PubMed ID: 6200550
    [No Abstract]   [Full Text] [Related]  

  • 16. Significant clinical response of activated carbon adsorbed-peplomycin against esophageal cancer: a pilot study.
    Kitamura K; Hagiwara A; Sasabe T; Kojima O; Takahashi T
    J Surg Oncol; 1993 Jan; 52(1):56-60. PubMed ID: 7680085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic local injection of a new drug-delivery format of peplomycin for superficial esophageal cancer: a pilot study.
    Hagiwara A; Takahashi T; Kojima O; Kitamura K; Sakakura C; Shoubayashi S; Osaki K; Iwamoto A; Lee M; Fujita K
    Gastroenterology; 1993 Apr; 104(4):1037-43. PubMed ID: 7681792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peplomycin-induced apoptosis in oral squamous carcinoma cells depends on bleomycin sensitivity.
    Okamura H; Morimoto H; Haneji T
    Oral Oncol; 2001 Jun; 37(4):379-85. PubMed ID: 11337271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination chemotherapy of vincristine, ifosfamide and peplomycin in patients with reactivated prostatic cancer].
    Kazama T; Katayama T; Umeda K; Akiya T; Nakada T
    Hinyokika Kiyo; 1986 Feb; 32(2):201-5. PubMed ID: 2425607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effect of Peplomycin on recurrent breast cancer].
    Kimura M; Koida T; Fukuda T
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1665-9. PubMed ID: 6191688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.